Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
1986-11-7
|
pubmed:databankReference | |
pubmed:abstractText |
The primary structure of human C1 inhibitor was determined by peptide and DNA sequencing. The single-chain polypeptide moiety of the intact inhibitor is 478 residues (52,869 Da), accounting for only 51% of the apparent molecular mass of the circulating protein (104,000 Da). The positions of six glucosamine-based and five galactosamine-based oligosaccharides were determined. Another nine threonine residues are probably also glycosylated. Most of the carbohydrate prosthetic groups (probably 17) are located at the amino-terminal end (residues 1-120) of the protein and are particularly concentrated in a region where the tetrapeptide sequence Glx-Pro-Thr-Thr, and variants thereof, is repeated 7 times. No phosphate was detected in C1 inhibitor. Two disulfide bridges connect cysteine-101 to cysteine-406 and cysteine-108 to cysteine-183. Comparison of the amino acid and cDNA sequences indicates that secretion is mediated by a 22-residue signal peptide and that further proteolytic processing does not occur. C1 inhibitor is a member of the large serine protease inhibitor (serpin) gene family. The homology concerns residues 120 through the C-terminus. The sequence was compared with those of nine other serpins, and conserved and nonconserved regions correlated with elements in the tertiary structure of alpha 1-antitrypsin. The C1 inhibitor gene maps to chromosome 11, p11.2-q13. C1 inhibitor genes of patients from four hereditary angioneurotic edema kindreds do not have obvious deletions or rearrangements in the C1 inhibitor locus. A HgiAI DNA polymorphism, identified following the observation of sequence variants, will be useful as a linkage marker in studies of mutant C1 inhibitor genes.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
4292-301
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:3756141-Amino Acid Sequence,
pubmed-meshheading:3756141-Base Sequence,
pubmed-meshheading:3756141-Carbohydrates,
pubmed-meshheading:3756141-Chromosome Mapping,
pubmed-meshheading:3756141-Chromosomes, Human, 6-12 and X,
pubmed-meshheading:3756141-Cloning, Molecular,
pubmed-meshheading:3756141-Complement C1 Inactivator Proteins,
pubmed-meshheading:3756141-DNA,
pubmed-meshheading:3756141-Genes,
pubmed-meshheading:3756141-Humans,
pubmed-meshheading:3756141-Hybrid Cells,
pubmed-meshheading:3756141-Models, Molecular,
pubmed-meshheading:3756141-Nucleic Acid Hybridization,
pubmed-meshheading:3756141-Polymorphism, Genetic,
pubmed-meshheading:3756141-Protein Conformation
|
pubmed:year |
1986
|
pubmed:articleTitle |
Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|